Thinning of the retina, the lining of nerve cells in the back of the eye, is linked to the loss of brain cells that produce dopamine, a new study has found.
“Our study is the first to show a link between the thinning of the retina and a known sign of the progression of the disease — the loss of brain cells that produce dopamine. We also found the thinner the retina, the greater the severity of disease. These discoveries may mean that neurologists may eventually be able to use a simple eye scan to detect Parkinson’s disease in its earliest stages, before problems with movement begin,”
said study author Jee-Young Lee, MD, PhD, of the Seoul Metropolitan Government – Seoul National University Boramae Medical Center in South Korea.
The study involved 49 people with an average age of 69 who were diagnosed with Parkinson’s disease an average of two years earlier but who had not yet started medication. They were compared to 54 people without the disease who were matched for age.
Researchers evaluated each study participant with a complete eye exam as well as high-resolution eye scans that use light waves to take pictures of each layer of the retina. In addition, 28 of the participants with Parkinson’s disease also had dopamine transporter positron emission tomography (PET) imaging to measure the density of dopamine-producing cells in the brain.
Researchers found retina thinning, most notably in the two inner layers of the five layers of the retina, in those with Parkinson’s disease. For example, for those with Parkinson’s disease, the inner most layer of the retina in one section of the eye had an average thickness of 35 micrometers compared to an average thickness of 37 mm for those without the disease.
Dopamine-producing Cell Loss
In addition, the thinning of the retina corresponded with the loss of brain cells that produce dopamine. It also corresponded with the severity of disease.
When disability from the disease is measured on a scale of one to five, the people with the most thinning of the retina, or thickness of less than 30 mm, had average scores of slightly over two, while people with the least thinning, or thickness of about 47 mm, had average scores of about 1.5.
“Larger studies are needed to confirm our findings and to determine just why retina thinning and the loss of dopamine-producing cells are linked,” said Lee. “If confirmed, retina scans may not only allow earlier treatment of Parkinson’s disease but more precise monitoring of treatments that could slow progression of the disease as well.”
The study does have some limitations, as the retina scans focused only on a limited area of the retina. The study was also a snapshot in time and did not follow participants over a long period of time.
The work was supported by the Seoul Metropolitan Government – Seoul National University Boramae Medical Center and the Korean Ministry of Education, Science and Technology.
Jeeyun Ahn, Jee-Young Lee, Tae Wan Kim, Eun Jin Yoon, Sohee Oh, Yu Kyeong Kim, Jong-Min Kim, Se Joon Woo, Ki Woong Kim, Beomseok Jeon
Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease
Neurology Aug 2018, 10.1212/WNL.0000000000006157; DOI: 10.1212/WNL.0000000000006157